To more accurately reflect the genetic mechanism that underpins both immune-mediated myositis (IMM) and non-exertional rhabdomyolysis, the name of the VGL’s DNA test has been updated from Immune-mediated Myositis (IMM/MYH1) to myosin-heavy chain myopathy (MYHM).